Rathbones Group PLC Takes Position in SPDR S&P Biotech ETF $XBI

Rathbones Group PLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, HoldingsChannel reports. The fund acquired 3,883 shares of the exchange traded fund’s stock, valued at approximately $473,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of XBI. JPMorgan Chase & Co. raised its stake in shares of SPDR S&P Biotech ETF by 27.3% during the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after acquiring an additional 2,900,633 shares during the last quarter. Assetmark Inc. increased its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after buying an additional 635,782 shares during the period. Greenwoods Asset Management Hong Kong Ltd. purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $55,613,000. Ameriprise Financial Inc. increased its position in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares during the period. Finally, Marks Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $28,857,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $131.66 on Friday. SPDR S&P Biotech ETF has a 1 year low of $78.00 and a 1 year high of $139.19. The company’s 50-day moving average is $129.82 and its 200 day moving average is $125.05. The stock has a market capitalization of $8.40 billion, a P/E ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.